miR-199a Knockdown Alleviates Insulin Resistance and Inflammation by Targeting DDIT4 via the PI3K/AKT Pathway in vitro and in vivo. - Cai YW; Tang LJ; Zhu Y; Ye SS; Chen TE (Diabetes, metabolic syndrome and obesity : targets and therapy, 2025)